CARE™ Perspectives Report from EULAR 2020 provides a summary of the most compelling stories and news presented. While CARE™ Rheumatology Faculty consider news and developments across all areas, this particular report focuses on rheumatoid arthritis – an area of particular change.
The report has three sections:
01. Retrospective Review
A look back on developments in rheumatoid arthritis (RA). This retrospective review looks at four areas of significant development: anti-TNF, IL inhibitors, JAK inhibitors, and biosimilars.
02. News and abstracts from EULAR 2020
03. State of CARE in Canada – Access to Innovation